NuGen Medical Devices Inc (NGMD) - Total Assets
Based on the latest financial reports, NuGen Medical Devices Inc (NGMD) holds total assets worth CA$4.29 Million CAD (≈ $3.10 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore NGMD debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
NuGen Medical Devices Inc - Total Assets Trend (2020–2025)
This chart illustrates how NuGen Medical Devices Inc's total assets have evolved over time, based on quarterly financial data. See NGMD net asset value for net asset value and shareholders' equity analysis.
NuGen Medical Devices Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
NuGen Medical Devices Inc's total assets of CA$4.29 Million consist of 93.0% current assets and 7.0% non-current assets.
| Asset Category | Amount (CAD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 73.1% |
| Accounts Receivable | CA$50.71K | 1.2% |
| Inventory | CA$498.23K | 11.6% |
| Property, Plant & Equipment | CA$0.00 | 0.0% |
| Intangible Assets | CA$13.32 Million | 310.5% |
| Goodwill | CA$0.00 | 0.0% |
Asset Composition Trend (2020–2025)
This chart illustrates how NuGen Medical Devices Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see NuGen Medical Devices Inc (NGMD) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: NuGen Medical Devices Inc's current assets represent 93.0% of total assets in 2025, an increase from 44.4% in 2020.
- Cash Position: Cash and equivalents constituted 73.1% of total assets in 2025, up from 1.8% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 310.0% of total assets, an increase from 54.0% in 2020.
- Asset Diversification: The largest asset category is intangible assets at 310.5% of total assets.
NuGen Medical Devices Inc Competitors by Total Assets
Key competitors of NuGen Medical Devices Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Bio-Rad Laboratories Inc
NYSE:BIO
|
USA | $9.79 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.01 Billion |
|
Affluent Medical SAS
PA:AFME
|
France | €59.84 Million |
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
4DMEDICAL Ltd
AU:4DX
|
Australia | AU$139.55 Million |
|
Anteris Technologies Global Corp
AU:AVR
|
Australia | AU$19.07 Million |
|
Imricor Medical Systems Inc
AU:IMR
|
Australia | AU$45.79 Million |
NuGen Medical Devices Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.10 | 5.84 | 0.65 |
| Quick Ratio | 0.96 | 5.60 | 0.65 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CA$363.04K | CA$6.47 Million | CA$-3.18 Million |
NuGen Medical Devices Inc - Advanced Valuation Insights
This section examines the relationship between NuGen Medical Devices Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 34.96 |
| Latest Market Cap to Assets Ratio | 0.57 |
| Asset Growth Rate (YoY) | -66.7% |
| Total Assets | CA$4.29 Million |
| Market Capitalization | $2.46 Million USD |
Valuation Analysis
Below Book Valuation: The market values NuGen Medical Devices Inc's assets below their book value (0.57x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: NuGen Medical Devices Inc's assets decreased by 66.7% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for NuGen Medical Devices Inc (2020–2025)
The table below shows the annual total assets of NuGen Medical Devices Inc from 2020 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CA$4.29 Million ≈ $3.10 Million |
-66.72% |
| 2024-12-31 | CA$12.89 Million ≈ $9.33 Million |
+85.65% |
| 2023-12-31 | CA$6.95 Million ≈ $5.02 Million |
+1.41% |
| 2022-12-31 | CA$6.85 Million ≈ $4.95 Million |
-22.56% |
| 2021-12-31 | CA$8.84 Million ≈ $6.40 Million |
-39.26% |
| 2020-12-31 | CA$14.56 Million ≈ $10.53 Million |
-- |
About NuGen Medical Devices Inc
NuGen Medical Devices Inc., a specialty medical device company, engages in developing and commercializing novel drug delivery technologies in Europe, Asia, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, vaccines, veterinary, home healthcare, and others. It also provides Ins… Read more